We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Procedure Reduces Pelvic Pain

By HospiMedica staff writers
Posted on 20 Sep 2005
A clinical study has demonstrated that a new laparoscopic surgical procedure significantly reduces pelvic pain in women caused by a retroverted or tipped uterus.

A retroverted uterus is a normal anatomic variant in 20-30% of U.S. More...
women. Within this patient population, 7-10% have symptoms of pelvic pain, dysmenorrhea (painful menstrual periods), or dyspareunia (painful intercourse) severe enough to seek treatment. The study involved 62 women, average age 29, with a retroverted uterus and chronic pain lasting six months or more, and moderate-to-severe dysmenorrhea. Each patient underwent the new procedure (alone or in combination with other laparoscopic procedures) and was monitored for 12 months. At 12 months after surgery, the mean scores for pelvic pain decreased by more than 50%, a significant change in this difficult-to-treat patient population.

The procedure, called UPLIFT (uterine positioning by ligament investment fixation and truncation), shortens and strengthens the round ligaments to reposition a tipped uterus to a normal position. UPLIFT is performed using a minimally invasive interventional laparoscopic technique with small incisions, and patients typically leave the hospital on the day of surgery. Women who undergo the procedure can still become pregnant, and full-term pregnancies with normal vaginal delivery have been documented. The UPLIFT procedure uses the Metra PS surgical response procedure kit of Inlet Medical (Eden Prairie, MN, USA; www.inletmedical.com), where Dr. James E. Carter introduced the procedure.

"The study results confirm earlier findings that our products play an important role in the successful laparoscopic surgical treatment of women who suffer severe pain related to a tipped uterus,” observed Lee Jones, president and CEO of Inlet Medical. The findings were reported in the August 2005 issue of The Journal of Reproductive Medicine.






Related Links:
Inlet Medical

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.